HII PsiQuantum Series II, a Series of HII PsiQuantum, LLC
Raised
$2M
Investors
40
Min Invest
$25,000
AltStreet Analysis
·Generated from EDGAR primary sources
HII PsiQuantum Series II, a series of HII PsiQuantum, LLC, filed this Form D on 2025-11-05 reporting $1.5M raised from 40 investors under Rule 506(b) and Section 3(c)(1). The offering has a $25K minimum investment and is structured as a pooled investment fund incorporated in Delaware. This entity is part of the Hiive platform, which operates 69 related EDGAR entities focused on private equity investments.
This private equity pooled investment fund uses the standard 506(b) exemption with 3(c)(1) Investment Company Act exclusion, typical for institutional and accredited investor vehicles. The $25K minimum represents an accessible entry point relative to traditional PE funds, and the $37.5K average check size ($1.5M / 40 investors) suggests retail-oriented distribution targeting smaller accredited investors.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Manasi Vydyanath
Executive Officer · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
